Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review-Authors' Reply
- PMID: 33988242
- DOI: 10.1093/ibd/izab088
Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review-Authors' Reply
Comment on
-
Real-World Effectiveness and Safety of Tofacitinib in Patients With Ulcerative Colitis: Systematic Review With Meta-Analysis.Inflamm Bowel Dis. 2022 Jan 5;28(1):32-40. doi: 10.1093/ibd/izab011. Inflamm Bowel Dis. 2022. PMID: 33586766
-
Tofacitinib in Acute Severe Ulcerative Colitis: Case Series and a Systematic Review.Inflamm Bowel Dis. 2021 Aug 19;27(9):e101-e103. doi: 10.1093/ibd/izab087. Inflamm Bowel Dis. 2021. PMID: 33988233 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical